ACOG practice bulletin: Thromboembolism in pregnancy

International Journal of Gynecology and Obstetrics

Volumn 75, Issue 2, 2001, Pages 203-212

  Barbour, L A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; WARFARIN;

DISEASE SEVERITY; HUMAN; LUNG EMBOLISM; MATERNAL MORTALITY; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; PUERPERIUM; RADIOGRAPHY; REVIEW; RISK FACTOR; SYMPTOMATOLOGY; THROMBOEMBOLISM; THROMBOPHILIA; UNITED STATES; VALVULAR HEART DISEASE; VEIN THROMBOSIS;

EID: 0034775825     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(01)00535-5     Document Type: Review

References (73)

1. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy
2. Thrombotic risk during pregnancy: A population study
3. Venous thromboembolism during pregnancy
4. Pregnancy-related mortality in the United States, 1987-1990
5. Genetic susceptibility to pregnancy-related venous thromboembolism: Roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations
6. The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis
7. Clinical manifestations and management of inherited thrombophilia: Retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S
8. The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis
9. Recurrence of venous thromboembolic disease and use of oral contraceptives
10. Recurrent thromboembolism in pregnancy and puerperium. Is there a need for thromboprophylaxis?
11. Heparin therapy during pregnancy. Risks to the fetus and mother
12. Heparin levels to guide thromboembolism prophylaxis during pregnancy
13. A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry
14. Bone mineral density during long-term prophylaxis with heparin in pregnancy
15. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin
16. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin
17. The clinical management of heparin-induced thrombocytopenia
18. Heparin and low-molecular-weight heparin: Mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety
19. Low molecular weight heparins
20. Absence of transplacental fragmin (Kabi) during second and third trimesters of pregnancy
21. Low molecular weight heparin Novo (LHN-1) does not cross the placenta during the second trimester of pregnancy
22. Low-molecular-weight heparin for obstetric thromboprophylaxis: Experience of sixty-nine pregnancies in sixty-one women at risk
23. Low-molecular-weight heparin during pregnancy and delivery: Preliminary experience with 41 pregnancies
24. Thromboembolic prophylaxis with low molecular weight heparin during pregnancy
25. May mothers given warfarin breast-feed their infants?
26. Anticoagulation of pregnant women with mechanical heart valves
27. Risks of anticoagulant therapy in pregnant women with artificial heart valves
28. Pregnancy in patients with prosthetic heart valves: The effects of anticoagulation on mother, fetus, and neonate
29. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses
30. Maternal and fetal sequelae of anticoagulation during pregnancy
31. Risk factors for pregnancy associated venous thromboembolism
32. Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: Study of 78 women
33. Antithrombin and its inherited deficiency states
34. Use of antithrombotic agents during pregnancy
35. Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience
36. Controversies in thromboembolic disease during pregnancy: A critical review
37. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium
38. The British Society for Haematology Guidelines on the use and monitoring of heparin 1992: Second revision
39. Guidelines on the prevention, investigation and management of thrombosis associated with pregnancy
40. Antithrombin III concentrates - Are they clinically useful?
41. Current concepts of anticoagulant therapy in pregnancy
42. Drug therapy: Low molecular weight heparin
43. Thrombophilia as a multigenic disorder
44. Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: Implications for prophylaxis
45. Inherited thrombotic disorders: An update
46. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
47. Activated protein C resistance can be associated with recurrent fetal loss
48. Fetal carriers of the factor V Leiden mutation are prone to miscarriage or placental infarction
49. Increased frequency of genetic thrombophilia in women with complications of pregnancy
50. Changes in protein C and protein S levels in normal pregnancy
51. Comparison of protein S functional and antigenic assays in normal pregnancy
52. Inherited thrombophilic states
53. Parameters of haemostasis during acute venous thrombosis
54. Diagnostic problems with venous thromboembolic disease in pregnancy
55. Serial impedance plethysmography in pregnant patients with clinically suspected deep-vein thrombosis. Clinical validity of negative findings
56. Risks to the fetus of radiologic procedures used in the diagnosis of maternal venous thromboembolic disease
57. Magnetic resonance imaging of deep venous thrombosis in pregnant women with lower extremity edema
58. Management of venous thromboembolism
59. Spiral computed tomography and pulmonary embolism: Current state
60. A randomized trial of spiral CT and ventilation perfusion scintigraphy for the diagnosis of pulmonary embolism
61. Spiral computed tomography in the evaluation of pulmonary embolism
62. Clinically suspected pulmonary embolism: Utility of spiral CT
63. Diagnosis of pulmonary embolism with magnetic resonance angiography
64. Diagnosis of pulmonary embolism with spiral computed tomography and magnetic resonance angiography
65. Thrombosis in pregnancy
66. Anticoagulants and thrombolytics during pregnancy
67. Antithrombotic therapy for venous thromboembolic disease
68. Thromboprophylaxis, coagulation disorders, and regional anesthesia
69. Epidural hematoma associated with enoxaparin
70. Neuraxial block and low-molecular-weight heparin: Balancing perioperative analgesia and thromboprophylaxis
71. European practice guidelines: Thromboembolism prophylaxis and regional anesthesia